Miki Naito-Campbell

Senior CRA at Ipsen

Miki Naito-Campbell's Professional Contact Details

Email (Verified)

****@ipsen.com

Get Email Address

+33 1 58 33 50 00

Location

Bromley, England, United Kingdom

Company

Ipsen

Person Seniority

senior

Miki Naito-Campbell's Current Company Details

Ipsen

Boulogne-Billancourt, ÃŽle-de-France, France • 2730 Employees

pharmaceuticals

* Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neurosciences and Rare Diseases. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Ipsen also has a well-established Consumer Healthcare business. With total sales close to â‚¬1.6 billion in 2016, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US). The Group has about 5,100 employees worldwide. * Ipsen est un groupe biopharmaceutique mondial de spÃ©cialitÃ© focalisÃ© sur l'innovation et la mÃ©decine de spÃ©cialitÃ©. Il dÃ©veloppe et commercialise des mÃ©dicaments innovants dans trois domaines thÃ©rapeutiques ciblÃ©s â€“ l'oncologie, les neurosciences et les maladies rares. L'engagement d'Ipsen en oncologie est illustrÃ© par son portefeuille croissant de thÃ©rapies visant Ã amÃ©liorer la vie des patients souffrant de cancers de la prostate, de tumeurs neuroendocrines, de cancers du rein et du pancrÃ©as. Ipsen bÃ©nÃ©ficie Ã©galement d'une prÃ©sence significative en SantÃ© Familiale. Avec un chiffre d'affaires de prÃ¨s de 1,6 milliard d'euros en 2016, Ipsen commercialise plus de 20 mÃ©dicaments dans plus de 115 pays, avec une prÃ©sence commerciale directe dans plus de 30 pays. La R&D d'Ipsen est focalisÃ©e sur ses plateformes technologiques diffÃ©renciÃ©es et innovantes situÃ©es au cÅ“ur des clusters mondiaux de la recherche biotechnologique et en sciences de la vie (Paris-Saclay, France ; Oxford, Royaume-Uni; Cambridge, Etats-Unis). Le Groupe rassemble environ 5 100 collaborateurs dans le monde.

Founded Year

1929

Organization Website

ipsen.com

Organization Languages

English

Organization Revenue

7000

Current Technologies

route 53

outlook

amazon aws